AKR1D1 and CYP7B1 mutations in patients with inborn errors of bile acid metabolism: Possibly underdiagnosed diseases
Background: Inborn errors of bile acid metabolism (IEBAM) cause rare but treatable genetic disorders that can present as neonatal cholestasis or neurological diseases. Without timely primary bile acid treatment, patients may develop liver failure early in life. This study aimed to analyze the types...
Saved in:
| Main Authors: | Ju-Yin Chen, Jia-Feng Wu, Akihiko Kimura, Hiroshi Nittono, Bang-Yu Liou, Chee-Seng Lee, Ho-Sheng Chen, Yu-Chun Chiu, Yen-Hsuan Ni, Steven Shinn-Forng Peng, Wang-Tso Lee, I-Jung Tsai, Mei-Hwei Chang, Huey-Ling Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-02-01
|
| Series: | Pediatrics and Neonatology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1875957219300956 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AKR1D1 and CFTR homozygous variants in an infant with combined bile acid synthesis defect and cystic fibrosis: first case report and management plan
by: Nehal M. Elkoofy, et al.
Published: (2025-08-01) -
Prognostic Potential of AKR1B1 in triple-negative breast cancer
by: Xiong Jing, et al.
Published: (2025-01-01) -
Cloning, expression, and purification of recombinant AKR1D1 for therapeutic applications
by: Shutevska Kristina, et al.
Published: (2025-03-01) -
AKR1C1 interacts with STAT3 to increase intracellular glutathione and confers resistance to oxaliplatin in colorectal cancer
by: Zhiwen Fu, et al.
Published: (2024-12-01) -
In silico characterization of the interaction of AKR1B1 with the deacetylase activation domain (DAD)
by: Francisco J. Gómez-Zaldívar, et al.
Published: (2025-04-01)